Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jan;43(1):111–115. doi: 10.1038/bjc.1981.17

Modulation of clonogenic human melanoma cells by follicle-stimulating hormone, melatonin, and nerve growth factor.

F L Meyskens Jr, S E Salmon
PMCID: PMC2010506  PMID: 6779847

Full text

PDF
111

Images in this article

112Fig. 1
on p.112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fisher R. I., Neifeld J. P., Lippman M. E. Oestrogen receptors in human malignant melanoma. Lancet. 1976 Aug 14;2(7981):337–339. doi: 10.1016/s0140-6736(76)92592-7. [DOI] [PubMed] [Google Scholar]
  2. Glovanella B. C., Stehlin J. S., Santamaria C., Yim S. O., Morgan A. C., Williams L. J., Jr, Leibovitz A., Fialkow P. J., Mumford D. M. Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes. J Natl Cancer Inst. 1976 Jun;56(6):1131–1142. doi: 10.1093/jnci/56.6.1131. [DOI] [PubMed] [Google Scholar]
  3. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  4. Kitano Y. Stimulation by melanocyte stimulating hormone and dibutyryl adenosine 3'5'-cyclic monophosphate of DNA synthesis in human melanocytes in vitro. Arch Dermatol Res. 1976 Nov 26;257(1):47–52. doi: 10.1007/BF00569112. [DOI] [PubMed] [Google Scholar]
  5. MISHIMA Y. New technic for comprehensive demonstration of melanin, premelanin, and tyrosinase sites. Combined dopapremelanin reaction. J Invest Dermatol. 1960 Jun;34:355–360. doi: 10.1038/jid.1960.62. [DOI] [PubMed] [Google Scholar]
  6. Meyskens F. L., Jr, Berglund E. B., Saxe D. F., Fuller B. B., Pacelli L. Z., Hall J. D., Ray C. G. Biological and biochemical properties of a human uveal melanocyte-derived cell line. In Vitro. 1980 Sep;16(9):775–780. doi: 10.1007/BF02619312. [DOI] [PubMed] [Google Scholar]
  7. Meyskens F. L., Jr, Fuller B. B. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Cancer Res. 1980 Jul;40(7):2194–2196. [PubMed] [Google Scholar]
  8. Meyskens F. L., Jr, Salmon S. E. Inhibition of human melanoma colony formation by retinoids. Cancer Res. 1979 Oct;39(10):4055–4057. [PubMed] [Google Scholar]
  9. Salmon S. E., Buick R. N. Preparation of permanent slides of intact soft-agar colony cultures of hematopoietic and tumor stem cells. Cancer Res. 1979 Mar;39(3):1133–1136. [PubMed] [Google Scholar]
  10. Salmon S. E., Hamburger A. W., Soehnlen B., Durie B. G., Alberts D. S., Moon T. E. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med. 1978 Jun 15;298(24):1321–1327. doi: 10.1056/NEJM197806152982401. [DOI] [PubMed] [Google Scholar]
  11. Selby P. J., Thomas J. M., Monaghan P., Sloane J., Peckham M. J. Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer. 1980 Jan;41(1):52–61. doi: 10.1038/bjc.1980.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sherwin S. A., Sliski A. H., Todaro G. J. Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1288–1292. doi: 10.1073/pnas.76.3.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES